Hestia Insight Inc. (HSTA) Aktienanalyse
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Mit einem Kurs von $ ist Hestia Insight Inc. (HSTA) ein Technology-Unternehmen mit einer Bewertung von 0. Bewertet mit 39/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.
Zuletzt analysiert: 16. März 2026Hestia Insight Inc. (HSTA) Technologieprofil & Wettbewerbsposition
Hestia Insight Inc. provides strategic consulting and capital market advisory services, primarily targeting micro, small, and medium-sized companies in the healthcare, biotech, and fintech sectors. Additionally, they offer healthcare management, technology development, and sales support, positioning them as a multifaceted service provider in specialized markets.
Investmentthese
Hestia Insight Inc. presents a unique investment proposition as a consulting and advisory firm operating at the intersection of healthcare, biotech, and fintech. The company's focus on micro, small, and medium-sized businesses allows it to cater to a niche market often underserved by larger consulting firms. Key value drivers include the potential for revenue growth through expansion of its service offerings and client base within its target sectors. However, investors may want to evaluate the risks associated with the company's small size, limited resources, and dependence on key personnel. The company's P/E ratio is -0.78 and Beta is -0.31 as of March 16, 2026.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- Hestia Insight Inc. operates with a small team of 3 employees, indicating a lean operational structure.
- The company's focus on micro, small, and medium-sized businesses in healthcare, biotech, and fintech allows for specialized service offerings.
- Hestia Insight provides a diverse range of services, including strategic consulting, capital market advisory, healthcare management, and technology development.
- The company's negative P/E ratio of -0.78 suggests that it is currently not profitable.
- The company's beta of -0.31 indicates a low correlation with the overall market, potentially offering some downside protection.
Wettbewerber & Vergleichsunternehmen
Staerken
- Specialized focus on healthcare, biotech, and fintech sectors.
- Integrated service offerings covering consulting, advisory, and technology development.
- Agile and responsive due to small company size.
- Established presence in Las Vegas.
Schwaechen
- Limited financial resources and capital.
- High dependence on key personnel.
- Small team size may limit scalability.
- OTC market listing may reduce investor confidence.
Katalysatoren
- Upcoming: Potential partnerships with fintech companies to expand service offerings in the fintech sector.
- Ongoing: Increasing demand for healthcare technology solutions for neurological and psychiatric disorders.
- Ongoing: Expansion of healthcare management services to address the needs of micro and small healthcare providers.
Risiken
- Potential: Limited financial resources may constrain growth initiatives and expansion plans.
- Potential: Dependence on key personnel could disrupt operations if they leave the company.
- Ongoing: Intense competition from larger consulting firms with greater resources and brand recognition.
- Potential: Evolving regulatory landscape in healthcare and fintech may require costly compliance efforts.
- Ongoing: OTC market listing may reduce investor confidence and limit access to capital.
Wachstumschancen
- Expansion of Healthcare Technology Development: Hestia Insight can capitalize on the growing demand for innovative healthcare technologies by expanding its development capabilities. The global healthcare technology market is projected to reach $280 billion by 2028, presenting a significant opportunity for Hestia Insight to develop and commercialize new solutions for neurological and psychiatric disorders. Timeline: 2-3 years.
- Strategic Partnerships with Fintech Companies: Collaborating with emerging fintech companies to provide specialized consulting services can drive growth. The fintech market is experiencing rapid growth, with a projected market size of $509 billion by 2029. Hestia Insight can leverage its expertise in capital markets and healthcare to offer valuable insights to fintech companies seeking to disrupt the healthcare industry. Timeline: 1-2 years.
- Increased Focus on Healthcare Management Services: The demand for efficient healthcare management services is increasing as healthcare providers seek to optimize operations and improve patient outcomes. Hestia Insight can expand its healthcare management offerings to address this need, targeting micro and small healthcare providers that may lack the resources to implement sophisticated management systems. Timeline: Ongoing.
- Geographic Expansion Beyond Las Vegas: Hestia Insight can explore opportunities to expand its geographic reach beyond Las Vegas, targeting other regions with a high concentration of healthcare, biotech, and fintech companies. This expansion can be achieved through strategic partnerships, remote service delivery, and the establishment of satellite offices. Timeline: 3-5 years.
- Development of Proprietary Healthcare Analytics Platform: Creating a proprietary healthcare analytics platform can provide Hestia Insight with a competitive advantage and generate recurring revenue streams. This platform can leverage data analytics and machine learning to provide insights into patient behavior, treatment outcomes, and market trends, enabling healthcare providers to make more informed decisions. Timeline: 2-3 years.
Chancen
- Expansion into new geographic markets.
- Development of proprietary healthcare technology solutions.
- Strategic partnerships with complementary businesses.
- Increased demand for specialized consulting services in target sectors.
Risiken
- Intense competition from larger consulting firms.
- Evolving regulatory landscape in healthcare and fintech.
- Economic downturn impacting client spending.
- Technological disruptions rendering existing services obsolete.
Wettbewerbsvorteile
- Specialized expertise in the intersection of healthcare, biotech, and fintech.
- Focus on micro, small, and medium-sized businesses, a niche often underserved by larger firms.
- Integrated service offerings spanning consulting, advisory, technology development, and sales support.
Ueber HSTA
Hestia Insight Inc., formerly known as Luxshmi Investments, Inc. until its name change in May 2019, is a Las Vegas-based firm providing strategic consulting and capital market advisory services. The company focuses on serving micro, small, and medium-sized enterprises within the healthcare, biotech, and fintech sectors. Hestia Insight offers a range of services, including healthcare management and patient services, development of healthcare technologies and analysis for neurological and psychiatric disorders, and medical supply sales support and management. The company also provides sales and marketing guidance to its clients. Hestia Insight's multifaceted approach aims to support its clients through various stages of growth and development, leveraging its expertise in both the financial and healthcare technology domains. The company operates with a small team of three employees.
Was das Unternehmen tut
- Provides strategic consulting services to micro, small, and medium-sized companies.
- Offers capital market advisory services.
- Delivers healthcare management and patient services.
- Develops healthcare technologies and analysis for neurological and psychiatric disorders.
- Provides medical supply sales support and management.
- Offers sales and marketing guidance and services.
Geschaeftsmodell
- Generates revenue through consulting fees for strategic advisory services.
- Earns fees from capital market advisory services, such as assisting with fundraising and M&A transactions.
- Derives income from healthcare management and patient service contracts.
- Potentially generates revenue from the licensing or sale of developed healthcare technologies.
Branchenkontext
Hestia Insight Inc. operates within the competitive landscape of consulting and advisory services, specifically targeting the healthcare, biotech, and fintech sectors. These sectors are characterized by rapid innovation, evolving regulatory environments, and significant capital flows. The market for consulting services in these sectors is driven by the need for specialized expertise in areas such as regulatory compliance, technology adoption, and market access. Hestia Insight's focus on micro, small, and medium-sized businesses positions it to capitalize on the demand for tailored solutions in these dynamic industries.
Wichtige Kunden
- Micro-sized companies in the healthcare sector.
- Small-sized businesses in the biotech industry.
- Medium-sized enterprises in the fintech sector.
Finanzdaten
Chart & Info
Hestia Insight Inc. (HSTA) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
-
Hovde Group Upgrades SouthState Bank (SSB) to Outperform
Yahoo Finance · 25. März 2026
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer HSTA.
Kursziele
Wall-Street-Kurszielanalyse fuer HSTA.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von HSTA auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Fuehrung: Edward C. Lee
Managing Director
Edward C. Lee serves as the Managing Director of Hestia Insight Inc., overseeing a small team of three employees. Information regarding his detailed career history, education, and previous roles is not available. His leadership is pivotal in guiding the strategic direction and operational activities of the company, particularly in the areas of consulting and capital market advisory services.
Erfolgsbilanz: Due to limited information available, Edward C. Lee's specific achievements and strategic decisions at Hestia Insight Inc. cannot be comprehensively assessed. However, under his leadership since May 2019, the company has focused on providing services to micro, small, and medium-sized companies in the healthcare, biotech, and fintech sectors.
HSTA OTC-Marktinformationen
The OTC Other tier represents the lowest tier of the OTC market, indicating that Hestia Insight Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited or no financial disclosure, which increases investment risk. Unlike companies listed on major exchanges like NYSE or NASDAQ, OTC Other companies face fewer regulatory requirements, potentially leading to less transparency and greater volatility.
- OTC-Stufe: OTC Other
- Offenlegungsstatus: Unknown
- Limited financial disclosure increases information asymmetry and investment risk.
- Low trading volume and wide bid-ask spreads can make it difficult to buy or sell shares.
- Lack of regulatory oversight increases the potential for fraud and manipulation.
- OTC Other companies may have a higher risk of delisting or going out of business.
- Limited analyst coverage and institutional interest can result in less price discovery and valuation uncertainty.
- Verify the company's registration and legal standing.
- Review available financial statements and disclosures, if any.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Understand the company's capital structure and ownership.
- Monitor trading volume and price volatility.
- Consult with a financial advisor before investing.
- Company's incorporation date and history.
- Physical business address and contact information.
- Presence of a functional website and online presence.
- Industry affiliations and memberships.
- Positive client testimonials or case studies (if available).
Haeufige Fragen zu HSTA
What are the key factors to evaluate for HSTA?
Hestia Insight Inc. (HSTA) currently holds an AI score of 39/100, indicating low score. Key strength: Specialized focus on healthcare, biotech, and fintech sectors.. Primary risk to monitor: Potential: Limited financial resources may constrain growth initiatives and expansion plans.. This is not financial advice.
How frequently does HSTA data refresh on this page?
HSTA prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven HSTA's recent stock price performance?
Recent price movement in Hestia Insight Inc. (HSTA) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Specialized focus on healthcare, biotech, and fintech sectors.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider HSTA overvalued or undervalued right now?
Determining whether Hestia Insight Inc. (HSTA) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying HSTA?
Before investing in Hestia Insight Inc. (HSTA), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding HSTA to a portfolio?
Potential reasons to consider Hestia Insight Inc. (HSTA) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Specialized focus on healthcare, biotech, and fintech sectors.. Additionally: Integrated service offerings covering consulting, advisory, and technology development.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of HSTA?
Yes, most major brokerages offer fractional shares of Hestia Insight Inc. (HSTA) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track HSTA's earnings and financial reports?
Hestia Insight Inc. (HSTA) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for HSTA earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Limited information available on Hestia Insight Inc. due to its OTC listing and small market capitalization.
- Financial data is limited and may not be fully reliable.
- AI analysis pending, which may provide additional insights.